{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:44:22Z","timestamp":1760132662692},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Currently, there is little evidence about the outcome of two-stage exchange arthroplasty for the treatment of knee periprosthetic joint infection (PJI) in patients with chronic viral hepatitis. To evaluate it, we set the primary outcome as infection recurrence, and the secondary outcome as the difference between patients diagnosed with hepatitis B virus or hepatitis C virus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>Between June, 2010 and December, 2016, 172 patients with knee PJIs were treated with two-stage exchange arthroplasty at our institute. Treatment success was defined using Delphi-based consensus. These patients were further divided into groups with or without chronic hepatitis. Variables were analyzed, including age, sex, comorbidities, microbiology, and operative methods. Minimum follow-up was 12\u2009months (mean, 35\u2009months; range, 12-85\u2009months).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 172 knee PJI patients, 25 were identified with chronic hepatitis. The infection recurrence rate in the hepatitis group (28%, 7 in 25) was significantly higher than that in the non-hepatitis group (9.5%, 14 in 147), <jats:italic>p<\/jats:italic>\u2009=\u20090.017. However, there was no significant difference in the infection recurrence rates between patients with HBV (24%, 4 in 16) and HCV (33.3%, 3 in 9). Regarding the outcomes of patients with infection recurrence, 4 of the non-hepatitis patients were treated with the debridement, antibiotic treatment, irrigation, and retention of prosthesis (DAIR) procedure, with a success rate of 75%. The other 17 patients (7 with hepatitis and 10 without) were treated with repeated two-stage exchange arthroplasty with 100% infection elimination rate until the final follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Knee PJI patients with chronic hepatitis have higher infection recurrence rate after two-stage exchange arthroplasty (28%).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04416-0","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T19:02:48Z","timestamp":1623524568000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Two-stage exchange Arthroplasty for knee Periprosthetic joint infection exhibit high infection recurrence rate in patients with chronic viral hepatitis"],"prefix":"10.1186","volume":"22","author":[{"given":"Jui-ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-hsiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-chih","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-hsun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-nung","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,12]]},"reference":[{"issue":"1","key":"4416_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11999-009-0945-0","volume":"468","author":"KJ Bozic","year":"2010","unstructured":"Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468(1):45\u201351.","journal-title":"Clin Orthop Relat Res"},{"key":"4416_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.knee.2020.12.024","volume":"28","author":"SA Sabah","year":"2021","unstructured":"Sabah SA, Alvand A, Price AJ. Revision knee replacement for prosthetic joint infection: epidemiology, clinical outcomes and health-economic considerations. Knee. 2021;28:417\u201321.","journal-title":"Knee"},{"issue":"2","key":"4416_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.arth.2017.09.021","volume":"33","author":"V Boddapati","year":"2018","unstructured":"Boddapati V, Fu MC, Mayman DJ, Su EP, Sculco PK, McLawhorn AS. Revision Total knee Arthroplasty for Periprosthetic joint infection is associated with increased postoperative morbidity and mortality relative to noninfectious revisions. J Arthroplast. 2018;33(2):521\u20136.","journal-title":"J Arthroplast"},{"issue":"4","key":"4416_CR4","doi-asserted-by":"publisher","first-page":"e62418","DOI":"10.1371\/journal.pone.0062418","volume":"8","author":"J Berrou","year":"2013","unstructured":"Berrou J, Fougeray S, Venot M, Chardiny V, Gautier JF, Dulphy N, et al. Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes. PLoS One. 2013;8(4):e62418.","journal-title":"PLoS One"},{"issue":"5","key":"4416_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.arth.2011.09.013","volume":"27","author":"R Iorio","year":"2012","unstructured":"Iorio R, Williams KM, Marcantonio AJ, Specht LM, Tilzey JF, Healy WL. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty. 2012;27(5):726\u2013729.e721.","journal-title":"J Arthroplasty"},{"issue":"9s","key":"4416_CR6","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1016\/j.arth.2017.04.065","volume":"32","author":"M Tarabichi","year":"2017","unstructured":"Tarabichi M, Shohat N, Kheir MM, Adelani M, Brigati D, Kearns SM, et al. Determining the threshold for hba1c as a predictor for adverse outcomes after total joint arthroplasty: a multicenter, retrospective study. J Arthroplasty. 2017;32(9s):S263\u2013S267.e261.","journal-title":"J Arthroplasty"},{"issue":"6","key":"4416_CR7","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1007\/s11999-008-0214-7","volume":"466","author":"FM Jaberi","year":"2008","unstructured":"Jaberi FM, Parvizi J, Haytmanek CT, Joshi A, Purtill J. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res. 2008;466(6):1368\u201371.","journal-title":"Clin Orthop Relat Res"},{"issue":"1 Suppl","key":"4416_CR8","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/j.otsr.2013.11.003","volume":"100","author":"S Parratte","year":"2014","unstructured":"Parratte S, Pesenti S, Argenson JN. Obesity in orthopedics and trauma surgery. Orthop Traumatol Surg Res. 2014;100(1 Suppl):S91\u20137.","journal-title":"Orthop Traumatol Surg Res"},{"issue":"6","key":"4416_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/SLA.0b013e31824f632d","volume":"255","author":"LT Sorensen","year":"2012","unstructured":"Sorensen LT. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg. 2012;255(6):1069\u201379.","journal-title":"Ann Surg"},{"issue":"12","key":"4416_CR10","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.5435\/JAAOS-D-16-00920","volume":"25","author":"JM Cancienne","year":"2017","unstructured":"Cancienne JM, Kandahari AM, Casp A, Novicoff W, Browne JA, Cui Q, et al. Complication rates after Total hip and knee Arthroplasty in patients with hepatitis C compared with matched control patients. J Am Acad Orthop Surg. 2017;25(12):e275\u201381.","journal-title":"J Am Acad Orthop Surg"},{"issue":"9","key":"4416_CR11","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/j.arth.2017.04.001","volume":"32","author":"K Issa","year":"2017","unstructured":"Issa K, Pierce TP, Harwin SF, Scillia AJ, McInerney VK, Mont MA. Does hepatitis C affect the clinical and patient-reported outcomes of primary Total hip Arthroplasty at midterm follow-up? J Arthroplast. 2017;32(9):2779\u201382.","journal-title":"J Arthroplast"},{"key":"4416_CR12","doi-asserted-by":"crossref","unstructured":"Kildow BJ, Politzer CS, DiLallo M, Bolognesi MP, Seyler TM. Short and long-term postoperative complications following total joint arthroplasty in patients with human immunodeficiency Virus, Hepatitis B, or Hepatitis C. J Arthroplasty. 2017;33(7): S86\u2013S92.","DOI":"10.1016\/j.arth.2017.10.061"},{"issue":"1","key":"4416_CR13","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12891-020-03570-1","volume":"21","author":"BA Rudelli","year":"2020","unstructured":"Rudelli BA, Giglio PN, de Carvalho VC, P\u00e9cora JR, Gurgel HMC, Gobbi RG, et al. Bacteria drug resistance profile affects knee and hip periprosthetic joint infection outcome with debridement, antibiotics and implant retention. BMC Musculoskelet Disord. 2020;21(1):574.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9 Suppl","key":"4416_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.arth.2016.03.028","volume":"31","author":"AR Cochran","year":"2016","unstructured":"Cochran AR, Ong KL, Lau E, Mont MA, Malkani AL. Risk of reinfection after treatment of infected Total knee Arthroplasty. J Arthroplast. 2016;31(9 Suppl):156\u201361.","journal-title":"J Arthroplast"},{"key":"4416_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874325001509010049","volume":"9","author":"L Claassen","year":"2015","unstructured":"Claassen L, Plaass C, Daniilidis K, Calliess T, von Lewinski G. Two-stage revision total knee arthroplasty in cases of periprosthetic joint infection: an analysis of 50 cases. Open Orthop J. 2015;9:49\u201356.","journal-title":"Open Orthop J"},{"issue":"1","key":"4416_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.knee.2014.10.005","volume":"22","author":"J Stammers","year":"2015","unstructured":"Stammers J, Kahane S, Ranawat V, Miles J, Pollock R, Carrington RW, et al. Outcomes of infected revision knee arthroplasty managed by two-stage revision in a tertiary referral Centre. Knee. 2015;22(1):56\u201362.","journal-title":"Knee"},{"issue":"2 -s","key":"4416_CR17","first-page":"92","volume":"88","author":"P Di Benedetto","year":"2017","unstructured":"Di Benedetto P, Di Benedetto ED, Buttironi MM, De Franceschi D, Beltrame A, Gissoni R, et al. Two-stage revision after total knee arthroplasty. Acta Bio Medica. 2017;88(2 -s):92\u20137.","journal-title":"Acta Bio Medica"},{"key":"4416_CR18","doi-asserted-by":"crossref","unstructured":"Bozhkova S, Tikhilov R, Labutin D, Denisov A, Shubnyakov I, Razorenov V, et al. Failure of the first step of two-stage revision due to polymicrobial prosthetic joint infection of the hip. J Orthop Traumatol. 2016;17(4):369\u201376.","DOI":"10.1007\/s10195-016-0417-8"},{"issue":"1","key":"4416_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13018-016-0428-4","volume":"11","author":"S Hoell","year":"2016","unstructured":"Hoell S, Sieweke A, Gosheger G, Hardes J, Dieckmann R, Ahrens H, et al. Eradication rates, risk factors, and implant selection in two-stage revision knee arthroplasty: a mid-term follow-up study. J Orthop Surg Res. 2016;11(1):93.","journal-title":"J Orthop Surg Res"},{"key":"4416_CR20","volume-title":"Periprosthetic infection recurrence after 2-stage exchange Arthroplasty: failure or fate? The Journal of arthroplasty","author":"GK Triantafyllopoulos","year":"2016","unstructured":"Triantafyllopoulos GK, Memtsoudis SG, Zhang W, Ma Y, Sculco TP, Poultsides LA. Periprosthetic infection recurrence after 2-stage exchange Arthroplasty: failure or fate? The Journal of arthroplasty; 2016."},{"key":"4416_CR21","doi-asserted-by":"crossref","unstructured":"Pellegrini A, Meani E, Macchi V, Legnani C. One-stage revision surgery provides infection eradication and satisfying outcomes for infected knee arthroplasty in selected patients. Expert Rev Anti-Infect Ther. 2020;18:1\u20134.","DOI":"10.1080\/14787210.2021.1851597"},{"issue":"39","key":"4416_CR22","doi-asserted-by":"publisher","first-page":"14156","DOI":"10.3748\/wjg.v20.i39.14156","volume":"20","author":"IP Balmasova","year":"2014","unstructured":"Balmasova IP, Yushchuk ND, Mynbaev OA, Alla NR, Malova ES, Shi Z, et al. Immunopathogenesis of chronic hepatitis B. World J Gastroenterol. 2014;20(39):14156\u201371.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"4416_CR23","first-page":"614","volume":"40","author":"J Parvizi","year":"2011","unstructured":"Parvizi J. New definition for periprosthetic joint infection. Am J Orthop. 2011;40(12):614\u20135.","journal-title":"Am J Orthop"},{"issue":"3","key":"4416_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2106\/JBJS.16.00290","volume":"99","author":"YH Hsu","year":"2017","unstructured":"Hsu YH, Hu CC, Hsieh PH, Shih HN, Ueng SW, Chang Y. Vancomycin and Ceftazidime in bone cement as a potentially effective treatment for knee Periprosthetic joint infection. J Bone Joint Surg Am. 2017;99(3):223\u201331.","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"4416_CR25","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1086\/313752","volume":"30","author":"J Wheat","year":"2000","unstructured":"Wheat J, Sarosi G, McKinsey D, Hamill R, Bradsher R, Johnson P, et al. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis. 2000;30(4):688\u201395.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4416_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1053\/j.gastro.2007.01.040","volume":"132","author":"SH Teh","year":"2007","unstructured":"Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132(4):1261\u20139.","journal-title":"Gastroenterology"},{"issue":"8","key":"4416_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646\u20139.","journal-title":"Br J Surg"},{"issue":"27","key":"4416_CR28","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJM199212313272703","volume":"327","author":"LB Seeff","year":"1992","unstructured":"Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, et al. Long-term mortality after transfusion-associated non-a, non-B hepatitis. The National Heart, Lung, and Blood Institute study group. N Engl J Med. 1992;327(27):1906\u201311.","journal-title":"N Engl J Med"},{"issue":"4","key":"4416_CR29","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1053\/j.gastro.2010.12.032","volume":"140","author":"F Kanwal","year":"2011","unstructured":"Kanwal F, Hoang T, Kramer JR, Asch SM, Goetz MB, Zeringue A, et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology. 2011;140(4):1182\u20131188.e1181.","journal-title":"Gastroenterology"},{"issue":"8","key":"4416_CR30","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/archsurg.1997.01430320082013","volume":"132","author":"HE Rice","year":"1997","unstructured":"Rice HE, O'Keefe GE, Helton WS, Johansen K. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surgery. 1997;132(8):880\u20134 discussion 884-885.","journal-title":"Arch Surgery"},{"issue":"6","key":"4416_CR31","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/hep.510290639","volume":"29","author":"LS Friedman","year":"1999","unstructured":"Friedman LS. The risk of surgery in patients with liver disease. Hepatology. 1999;29(6):1617\u201323.","journal-title":"Hepatology"},{"key":"4416_CR32","doi-asserted-by":"crossref","unstructured":"Neves J, de Araujo NM, Oliveira P. Martins dos Santos J, Malo P: risk factors for implant failure and Peri-implant pathology in systemic compromised patients. J Prosthodont. 2016;27(5):409\u201315.","DOI":"10.1111\/jopr.12508"},{"issue":"1","key":"4416_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00000542-199901000-00008","volume":"90","author":"A Ziser","year":"1999","unstructured":"Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90(1):42\u201353.","journal-title":"Anesthesiology"},{"issue":"1","key":"4416_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12891-017-1622-1","volume":"18","author":"SW Jhan","year":"2017","unstructured":"Jhan SW, Lu YD, Lee MS, Lee CH, Wang JW, Kuo FC. The risk factors of failed reimplantation arthroplasty for periprosthetic hip infection. BMC Musculoskelet Disord. 2017;18(1):255.","journal-title":"BMC Musculoskelet Disord"},{"key":"4416_CR35","first-page":"345475","volume":"2015","author":"SY Chen","year":"2015","unstructured":"Chen SY, Hu CC, Chen CC, Chang YH, Hsieh PH. Two-stage revision Arthroplasty for Periprosthetic hip infection: mean follow-up of ten years. Biomed Res Int. 2015;2015:345475.","journal-title":"Biomed Res Int"},{"issue":"2 Suppl","key":"4416_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.arth.2013.09.043","volume":"29","author":"C Haasper","year":"2014","unstructured":"Haasper C, Buttaro M, Hozack W, Aboltins CA, Borens O, Callaghan JJ, et al. Irrigation and debridement. J Arthroplast. 2014;29(2 Suppl):100\u20133.","journal-title":"J Arthroplast"},{"issue":"8","key":"4416_CR37","doi-asserted-by":"publisher","first-page":"786.e789","DOI":"10.1016\/j.cmi.2015.04.012","volume":"21","author":"E Tornero","year":"2015","unstructured":"Tornero E, Morata L, Martinez-Pastor JC, Bori G, Climent C, Garcia-Velez DM, et al. KLIC-score for predicting early failure in prosthetic joint infections treated with debridement, implant retention and antibiotics. Clin Microbiol Infect. 2015;21(8):786.e789\u201317.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04416-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04416-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04416-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T19:03:43Z","timestamp":1623524623000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04416-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4416"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04416-0","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,12]]},"assertion":[{"value":"16 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects and approval from the Chang Gung medical foundation institutional review board (201902172B0) was acquired. All methods were performed in accordance with Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"538"}}